No-deal Brexit likely to cause medicine delays

The chief executive of University Hospitals Birmingham has warned that NHS trusts could ‘quickly run out of vital medicine’ in the event of a no-deal Brexit.

Despite NHS stockpiling and the Department of Health reiterating that planning for a no-deal Brexit was ‘ongoing’, Dr David Rosser said in a paper presented to the trust board that shortages would likely occur due to ‘unprecedented’ distribution challenges.

Claiming that a Department of Health report into which medicines were likely to face shortages had not been made available to NHS trusts, Rosser said that the availability of medicines, devices and clinical supplies was ‘by far the greatest concern’ when looking at the potential for major operational impact and severe and widespread risks to public safety.

In a further warning, Rosser said that such shortages would lead to most non-urgent operations being postponed and that a ‘fractious no-deal scenario’ could have a major impact on EU staff working in the NHS.

Event Diary

This story was first published in digitalhealth.net

Supplier Profiles

CDC success at Victoria Infirmary, Northwich creates ideal model for future patient pathway reforms

Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients

Gain valuable insight with Adveco for gas to electric decarbonisation projects

Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho